Atara Biotherapeutics Announces the Completion of the Acquisition of Its Cell Therapy Manufacturing Facility & Commencement of Long-Term Strategic Partnership with FujifilmBusiness Wire • 04/04/22
Eikon Therapeutics Announces the Appointment of Dr. Roy D. Baynes as Executive Vice President and Chief Medical OfficerBusiness Wire • 03/23/22
Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 42nd Annual Virtual Healthcare ConferenceBusiness Wire • 03/02/22
Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/01/22
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational ProgressBusiness Wire • 02/28/22
Is a Surprise Coming for Atara Biotherapeutics (ATRA) This Earnings Season?Zacks Investment Research • 02/24/22
Atara Biotherapeutics Shares Fall After Reporting Patient Death In ATA2271 Autologous CAR T TrialBenzinga • 02/18/22
Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022Business Wire • 02/17/22
Atara Biotherapeutics Enters Strategic Manufacturing Partnership with FujifilmBusiness Wire • 01/26/22
New Landmark Nature Study Provides Long-Sought Mechanistic Link Between EBV and Multiple Sclerosis, Extending Findings from Recent Paper in Science That Identified EBV as the Leading Cause of Multiple SclerosisBusiness Wire • 01/24/22
Atara Biotherapeutics to Present Recent Progress and Key Upcoming Catalysts at the 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/10/22
Be The Match BioTherapies® and Atara Biotherapeutics Announce Multi-Year Partnership ExtensionBusiness Wire • 01/06/22
Atara Biotherapeutics to Present at the 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/05/22
Atara Biotherapeutics Announces Positive Results from Pivotal Phase 3 Trial (ALLELE) of Tab-cel® at the 63rd American Society of Hematology (ASH) Annual MeetingBusiness Wire • 12/14/21
Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021Business Wire • 12/09/21
European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabelecleucel for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative DiseaseBusiness Wire • 11/30/21
Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
How Much Upside is Left in Atara Biotherapeutics (ATRA)? Wall Street Analysts Think 48%Zacks Investment Research • 11/04/21
Atara Biotherapeutics to Present Eight Abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting, Including First Presentation of Tab-cel® Pivotal Phase 3 (ALLELE) DataBusiness Wire • 11/04/21